Abstract
We report that individuals carrying the CCR5Δ32 mutation, a naturally occurring variant of the C-C chemokine receptor 5 (CCR5), are at reduced risk of developing asthma. These data suggest a possible explanation for the high prevalence of this mutation in the general population.
Original language | English |
---|---|
Pages (from-to) | 1264-1265 |
Number of pages | 2 |
Journal | The Lancet |
Volume | 354 |
Issue number | 9186 |
DOIs | |
Publication status | Published - 9 Oct 1999 |
Externally published | Yes |
ASJC Scopus subject areas
- General Medicine